Topical Wound Applications in Preclinical and Clinical Settings In animal models of open and ischemic wounds, GHK-Cucontaining preparations appeared to align with faster closure metrics, earlier granulation, and more prominent neovascular features than control comparators
Marjan S/A Pharma Company for provided financial support for this research
Other facts about the use experience come by deduction of the scientific literature on DSIP and other peptides, as well as our extensive interactions with peptide-prescribing physicians: Preparation: If used as an injectable, DSIP ought to come as a dry powder that needs to be reconstituted into a solution
Third Party Tested Independent third party laboratories verify purity, potency, and accurate dosing to ensure the highest quality and safety standards
It is illegal to import or possess without a prescription
Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu